secwatch.observer — SEC 8-K summary
======================================

Issuer:     FILANA THERAPEUTICS, INC. (FLNA)
CIK:        0001069530
Form:       8-K
Filed at:   2023-05-01T23:59:59+00:00
Accession:  0001493152-23-015041
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.02, 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cassava Sciences terminates $100M SVB ATM, enters $200M ATM with JonesTrading
-----------------------------------------------------------------------------

- Terminated SVB Securities ATM agreement effective May 1, 2023; no shares ever sold under that facility.
- Entered new Capital on Demand Sales Agreement with JonesTrading for up to $200M aggregate offering price.
- New ATM replaces prior program; shares sold via 'at the market' offerings under new shelf registration statement S-3.
- JonesTrading receives commission up to 3% of gross proceeds; company reimburses certain expenses.
- No obligation to sell shares; company can set minimum price and suspend or terminate offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069530/000149315223015041/0001493152-23-015041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069530/000149315223015041/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-015041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer